Cargando…
Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 era
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801769/ https://www.ncbi.nlm.nih.gov/pubmed/34973215 http://dx.doi.org/10.1016/S1470-2045(21)00695-1 |
| _version_ | 1784642536044756992 |
|---|---|
| author | Abid, Muhammad Bilal |
| author_facet | Abid, Muhammad Bilal |
| author_sort | Abid, Muhammad Bilal |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8801769 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88017692022-01-31 Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 era Abid, Muhammad Bilal Lancet Oncol Comment Elsevier Ltd. 2022-01 2021-12-29 /pmc/articles/PMC8801769/ /pubmed/34973215 http://dx.doi.org/10.1016/S1470-2045(21)00695-1 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Abid, Muhammad Bilal Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 era |
| title | Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 era |
| title_full | Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 era |
| title_fullStr | Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 era |
| title_full_unstemmed | Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 era |
| title_short | Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 era |
| title_sort | early immunomodulators with car t-cell immunotherapy in the covid-19 era |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801769/ https://www.ncbi.nlm.nih.gov/pubmed/34973215 http://dx.doi.org/10.1016/S1470-2045(21)00695-1 |
| work_keys_str_mv | AT abidmuhammadbilal earlyimmunomodulatorswithcartcellimmunotherapyinthecovid19era |